Plain-English translation of NCT05269680 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world registry study that collects information from patients who have received the MINIject implant for open-angle glaucoma. Researchers want to understand how the device works in actual clinical practice, how patients feel about their recovery, and whether any safety concerns arise over a two-year follow-up period.
While the MINIject has been approved and is already in use, this study gathers detailed information about how the treatment performs outside of controlled clinical trials and what patients actually experience living with the implant.
You would have already received or be planning to receive the MINIject implant as part of your regular medical care. After your surgery, you would return for follow-up visits over two years where your eye surgeon collects information about how you're healing, how well the implant is working, and any side effects or concerns. You may also be asked to share your own experiences about how the treatment has affected your daily life and vision.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
Austria
Germany